Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance

[1]  S. O’Rahilly,et al.  Genetic syndromes of severe insulin resistance. , 2018, Current opinion in genetics & development.

[2]  S. Frye,et al.  Retraction of "The L3MBTL3 Methyl-Lysine Reader Domain Functions As a Dimer". , 2017, ACS chemical biology.

[3]  C. Viscoli,et al.  Pioglitazone after Ischemic Stroke or Transient Ischemic Attack. , 2016, The New England journal of medicine.

[4]  Samuel E. Jones,et al.  Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease , 2016, Diabetes.

[5]  C. Fagour,et al.  Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: toward recommendation for molecular testing and management , 2016, Clinical genetics.

[6]  Dermot F. Reilly,et al.  Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease , 2018 .

[7]  S. Frye,et al.  The L3MBTL3 Methyl-Lysine Reader Domain Functions As a Dimer. , 2016, ACS chemical biology.

[8]  Alexander E. Lopez,et al.  Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease. , 2016, The New England journal of medicine.

[9]  D. Tanné,et al.  Pioglitazone after Ischemic Stroke or Transient Ischemic Attack. , 2016, The New England journal of medicine.

[10]  Po-Ru Loh,et al.  A Robust Example of Collider Bias in a Genetic Association Study. , 2016, American journal of human genetics.

[11]  Ellen M. Schmidt,et al.  New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk , 2016, Nature Communications.

[12]  H. Grallert,et al.  Numerous Genes in Loci Associated With Body Fat Distribution Are Linked to Adipose Function , 2016, Diabetes.

[13]  T. Assimes,et al.  Erratum: Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene (American Society for Clinical Investigation (2015)125:4 (1739-1751) DOI 10.1172/JCI74692) , 2016 .

[14]  G. Shulman,et al.  The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. , 2016, The Journal of clinical investigation.

[15]  S. Anker,et al.  Pioglitazone after Ischemic Stroke or Transient Ischemic Attack. , 2016, The New England journal of medicine.

[16]  T. Assimes,et al.  Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. , 2016, The Journal of clinical investigation.

[17]  Brian Raught,et al.  A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface , 2015, Cell.

[18]  Tom R. Gaunt,et al.  The UK10K project identifies rare variants in health and disease , 2016 .

[19]  J. Danesh,et al.  A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .

[20]  D. Savage,et al.  The genetics of lipid storage and human lipodystrophies. , 2015, Trends in molecular medicine.

[21]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[22]  U. Smith.  Abdominal obesity: a marker of ectopic fat accumulation. , 2015, The Journal of clinical investigation.

[23]  Peter Kraft,et al.  Adjusting for heritable covariates can bias effect estimates in genome-wide association studies. , 2015, American journal of human genetics.

[24]  David M. Herrington,et al.  Multiple rare alleles at LDLR and APOA5 confer risk for early-onset myocardial infarction , 2014, Nature.

[25]  F. Karpe,et al.  Biology of upper-body and lower-body adipose tissue—link to whole-body phenotypes , 2015, Nature Reviews Endocrinology.

[26]  Hynek Pikhart,et al.  HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials , 2015, The Lancet.

[27]  J. Hirschhorn,et al.  Biological interpretation of genome-wide association studies using predicted gene functions , 2015, Nature Communications.

[28]  Tamara S. Roman,et al.  New genetic loci link adipose and insulin biology to body fat distribution , 2014, Nature.

[29]  Richard Durbin,et al.  Gene-gene and gene-environment interactions detected by transcriptome sequence analysis in twins , 2014, Nature Genetics.

[30]  Tom R. Gaunt,et al.  The UK10K project identifies rare variants in health and disease , 2015, Nature.

[31]  J. Lane,et al.  Development of an OP9 Derived Cell Line as a Robust Model to Rapidly Study Adipocyte Differentiation , 2014, PloS one.

[32]  M. McCarthy,et al.  Common Genetic Variants Highlight the Role of Insulin Resistance and Body Fat Distribution in Type 2 Diabetes, Independent of Obesity , 2014, Diabetes.

[33]  P. Munroe,et al.  Genetic Evidence for a Normal-Weight “Metabolically Obese” Phenotype Linking Insulin Resistance, Hypertension, Coronary Artery Disease, and Type 2 Diabetes , 2014, Diabetes.

[34]  John Spertus,et al.  Inactivating mutations in NPC1L1 and protection from coronary heart disease. , 2014, The New England journal of medicine.

[35]  M. McCarthy,et al.  Distinct Developmental Profile of Lower-Body Adipose Tissue Defines Resistance Against Obesity-Associated Metabolic Complications , 2014, Diabetes.

[36]  G. Shulman.  Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. , 2014, The New England journal of medicine.

[37]  Ross M. Fraser,et al.  Defining the role of common variation in the genomic and biological architecture of adult human height , 2014, Nature Genetics.

[38]  S. O’Rahilly,et al.  Hypomorphism in human NSMCE2 linked to primordial dwarfism and insulin resistance. , 2014, The Journal of clinical investigation.

[39]  J. Al-Aama,et al.  A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes , 2014, Nature.

[40]  M. Hayden,et al.  Identification of four novel genes contributing to familial elevated plasma HDL cholesterol in humans[S] , 2014, Journal of Lipid Research.

[41]  B. Nordestgaard,et al.  Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. , 2014, The New England journal of medicine.

[42]  P. Arner,et al.  Adipose tissue and metabolic alterations: regional differences in fat cell size and number matter, but differently: a cross-sectional study. , 2014, The Journal of clinical endocrinology and metabolism.

[43]  K. Petersen,et al.  The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes , 2014, Nature.

[44]  Mark I. McCarthy,et al.  A Central Role for GRB10 in Regulation of Islet Function in Man , 2014, PLoS genetics.

[45]  Peggy Hall,et al.  The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..

[46]  Inactivating Mutations in NPC 1 L 1 and Protection from Coronary Heart Disease , 2014 .

[47]  Andrew D. Johnson,et al.  Synthesis of 53 tissue and cell line expression QTL datasets reveals master eQTLs , 2014, BMC Genomics.

[48]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[49]  F. Hu,et al.  Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. , 2013, The lancet. Diabetes & endocrinology.

[50]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[51]  Patrick Callier,et al.  PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. , 2013, American journal of human genetics.

[52]  Sahar Mansour,et al.  Mutations in PIK3R1 cause SHORT syndrome. , 2013, American journal of human genetics.

[53]  Stefan Johansson,et al.  SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. , 2013, American journal of human genetics.

[54]  Ross M. Fraser,et al.  Sex-stratified Genome-wide Association Studies Including 270,000 Individuals Show Sexual Dimorphism in Genetic Loci for Anthropometric Traits , 2013, PLoS genetics.

[55]  G. Reaven,et al.  Comparison of the abilities of the plasma triglyceride/high-density lipoprotein cholesterol ratio and the metabolic syndrome to identify insulin resistance , 2013, Diabetes & vascular disease research.

[56]  Tanya M. Teslovich,et al.  Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways , 2012, Nature Genetics.

[57]  Tanya M. Teslovich,et al.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.

[58]  Claude Bouchard,et al.  A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance , 2012, Nature Genetics.

[59]  M. Czech,et al.  What causes the insulin resistance underlying obesity? , 2012, Current opinion in endocrinology, diabetes, and obesity.

[60]  R. Collins.  What makes UK Biobank special? , 2012, The Lancet.

[61]  O. Delaneau,et al.  A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.

[62]  Manolis Kellis,et al.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..

[63]  N Slimani,et al.  Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study , 2011, Diabetologia.

[64]  Christian Gieger,et al.  Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile , 2011, Nature Genetics.

[65]  David M. Evans,et al.  Adult height variants affect birth length and growth rate in children , 2011, Human molecular genetics.

[66]  Mark I. McCarthy,et al.  Identification of an imprinted master trans-regulator at the KLF14 locus related to multiple metabolic phenotypes , 2011, Nature Genetics.

[67]  Devjit Tripathy,et al.  Pioglitazone for diabetes prevention in impaired glucose tolerance. , 2011, The New England journal of medicine.

[68]  D. Mozaffarian,et al.  Association Between Adiposity in Midlife and Older Age and Risk of Diabetes in Older Adults , 2010 .

[69]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[70]  K. Petersen,et al.  Lipid-induced insulin resistance: unravelling the mechanism , 2010, The Lancet.

[71]  D. Mozaffarian,et al.  Association between adiposity in midlife and older age and risk of diabetes in older adults. , 2010, JAMA.

[72]  E. Dermitzakis,et al.  Candidate Causal Regulatory Effects by Integration of Expression QTLs with Complex Trait Genetic Associations , 2010, PLoS genetics.

[73]  A. Vidal-Puig,et al.  Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective. , 2010, Biochimica et biophysica acta.

[74]  P. Ridker,et al.  Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis , 2009, PLoS genetics.

[75]  Andrew D. Johnson,et al.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..

[76]  M. Schulze,et al.  General and abdominal adiposity and risk of death in Europe. , 2008, The New England journal of medicine.

[77]  M. Czech,et al.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.

[78]  A. Lincoff,et al.  Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. , 2007, JAMA.

[79]  G. Shulman,et al.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue. , 2007, The Journal of clinical investigation.

[80]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[81]  Peter Almgren,et al.  Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. , 2007, The Journal of clinical investigation.

[82]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[83]  S. Nissen,et al.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.

[84]  Laxman Yetukuri,et al.  PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism , 2007, PLoS genetics.

[85]  J. Després,et al.  Abdominal obesity and metabolic syndrome , 2006, Nature.

[86]  S. O’Rahilly,et al.  Leptin Deficiency Unmasks the Deleterious Effects of Impaired Peroxisome Proliferator–Activated Receptor γ Function (P465L PPARγ) in Mice , 2006, Diabetes.

[87]  M. Laakso,et al.  Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.

[88]  R. Unger.  Lipid overload and overflow: metabolic trauma and the metabolic syndrome , 2003, Trends in Endocrinology & Metabolism.

[89]  A. Chait,et al.  Köbberling type of familial partial lipodystrophy: an underrecognized syndrome. , 2003, Diabetes care.

[90]  P. Arner.  The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones , 2003, Trends in Endocrinology & Metabolism.

[91]  J. Friedman.  A War on Obesity, Not the Obese , 2003, Science.

[92]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[93]  M. Reitman,et al.  Leptin-replacement therapy for lipodystrophy. , 2002, The New England journal of medicine.

[94]  J. Samet,et al.  Food and Drug Administration , 2007, BMJ : British Medical Journal.

[95]  B. Egan,et al.  Insulin resistance and cardiovascular disease. , 2001, American journal of hypertension.

[96]  E. Danforth.  Failure of adipocyte differentiation causes type II diabetes mellitus? , 2000, Nature Genetics.

[97]  J. Friedman,et al.  Obesity in the new millennium , 2000, Nature.

[98]  G. Shulman,et al.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. , 2000, The Journal of clinical investigation.

[99]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[100]  R. Hammer,et al.  Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy , 1999, Nature.

[101]  N. Day,et al.  EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.

[102]  J. Vague.  The Degree of Masculine Differentiation of Obesities , 1996 .

[103]  K. Fox.  Hypertension and heart disease. , 1996, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[104]  S. Humphries,et al.  A common variant in the gene for lipoprotein lipase (Asp9→Asn) : functional implications and prevalence in normal and hyperlipidemic subjects , 1995 .

[105]  G. Miller,et al.  A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. , 1994, Arteriosclerosis, thrombosis, and vascular biology.

[106]  Y. Ouchi,et al.  Mutational analysis of human lipoprotein lipase by carboxy-terminal truncation. , 1993, Journal of lipid research.

[107]  S. Lillioja,et al.  Obesity and insulin resistance: lessons learned from the Pima Indians. , 1988, Diabetes/metabolism reviews.

[108]  R. F. Goldman,et al.  The effect of diet on thermogenesis in acquired lipodystrophy. , 1979, Metabolism: clinical and experimental.

[109]  J. Vague,et al.  The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. , 1956, The American journal of clinical nutrition.

[110]  R. D. Lawrence.  Types of Human Diabetes , 1951, Proceedings of the Royal Society of Medicine.